Campbell W A, Thompson N L
Division of Medical Oncology, Brown University School of Medicine and Graduate Program in Pathobiology, Rhode Island Hospital, Providence, Rhode Island 02903, USA.
J Biol Chem. 2001 May 18;276(20):16877-84. doi: 10.1074/jbc.M008248200. Epub 2001 Feb 22.
l-amino acid transporter-1 (LAT1) is a highly conserved gene identified as a light chain of the CD98 amino acid transporter and cellular activation marker. In our previous studies we found increased expression of LAT1 in primary human cancers. We have demonstrated also that LAT1 response to arginine availability is lost in transformed and tumorigenic cells such that expression is constitutively high. System l-amino acid transport activity correlates with changes in LAT1. To assess the functional relevance of increased LAT1 expression and the requirement for 4F2 heavy chain, we overexpressed these CD98 subunits together and separately in nontransformed hepatocytes and fibroblasts. Antigen tags in the expression constructs confirmed that expressed proteins were localized to both cytoplasmic and plasma membrane locations within the cells. Overexpression of LAT1 alone in mouse hepatocytes, but not fibroblasts, was sufficient to increase system l transport, and these cells displayed a growth advantage in conditions of limited arginine. Our results suggest that loss of regulation leading to constitutive expression of LAT1 can contribute to oncogenesis. We hypothesize that the altered LAT1 expression observed in hepatocarcinogenesis gives cells a growth or survival advantage through increased transport activity in a tumor microenvironment of limited amino acid availability.
L-氨基酸转运体-1(LAT1)是一种高度保守的基因,被鉴定为CD98氨基酸转运体的轻链和细胞活化标志物。在我们之前的研究中,我们发现原发性人类癌症中LAT1的表达增加。我们还证明,在转化细胞和致瘤细胞中,LAT1对精氨酸可用性的反应丧失,从而使其表达持续处于高水平。系统L-氨基酸转运活性与LAT1的变化相关。为了评估LAT1表达增加的功能相关性以及对4F2重链的需求,我们在未转化的肝细胞和成纤维细胞中共同或分别过表达这些CD98亚基。表达构建体中的抗原标签证实,表达的蛋白质定位于细胞内的细胞质和质膜位置。单独在小鼠肝细胞而非成纤维细胞中过表达LAT1足以增加系统L转运,并且这些细胞在精氨酸有限的条件下表现出生长优势。我们的结果表明,导致LAT1组成型表达的调节丧失可能有助于肿瘤发生。我们假设在肝癌发生过程中观察到的LAT1表达改变通过在氨基酸可用性有限的肿瘤微环境中增加转运活性,赋予细胞生长或生存优势。